<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2016.01462</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Proteomics Analysis Revealed that Crosstalk between <italic>Helicobacter pylori</italic> and <italic>Streptococcus mitis</italic> May Enhance Bacterial Survival and Reduces Carcinogenesis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Khosravi</surname> <given-names>Yalda</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/324832/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Loke</surname> <given-names>Mun Fai</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/211920/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Goh</surname> <given-names>Khean Lee</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/106099/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Vadivelu</surname> <given-names>Jamuna</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Medical Microbiology, Faculty of Medicine, University of Malaya</institution> <country>Kuala Lumpur, Malaysia</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Medicine, Faculty of Medicine, University of Malaya</institution> <country>Kuala Lumpur, Malaysia</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: George Tsiamis, University of Patras, Greece</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Michael Kevin Watters, Valparaiso University, USA; Dave Siak-Wei Ow, Bioprocessing Technology Institute (A<sup>&#x0002A;</sup>STAR), Singapore</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Jamuna Vadivelu <email>jamuna&#x00040;ummc.edu.my</email></p></fn>
<fn fn-type="other" id="fn002"><p>This article was submitted to Systems Microbiology, a section of the journal Frontiers in Microbiology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>09</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>7</volume>
<elocation-id>1462</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>06</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>09</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2016 Khosravi, Loke, Goh and Vadivelu.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Khosravi, Loke, Goh and Vadivelu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><p><italic>Helicobacter pylori</italic> is the dominant species of the human gastric microbiota and is present in the stomach of more than half of the human population worldwide. Colonization by <italic>H. pylori</italic> causes persistent inflammatory response and <italic>H. pylori</italic>-induced gastritis is the strongest singular risk factor for the development of gastric adenocarcinoma. However, only a small proportion of infected individuals develop malignancy. Besides <italic>H. pylori</italic>, other microbial species have also been shown to be related to gastritis. We previously reported that interspecies microbial interaction between <italic>H. pylori</italic> and <italic>S. mitis</italic> resulted in alteration of their metabolite profiles. In this study, we followed up by analyzing the changing protein profiles of <italic>H. pylori</italic> and <italic>S. mitis</italic> by LC/Q-TOF mass spectrometry to understand the different response of the two bacterial species in a multi-species micro-environment. Differentially-expressed proteins in mono- and co-cultures could be mapped into 18 biological pathways. The number of proteins involve in RNA degradation, nucleotide excision repair, mismatch repair, and lipopolysaccharide (LPS) biosynthesis were increased in co-cultured <italic>H. pylori</italic>. On the other hand, fewer proteins involve in citrate cycle, glycolysis/ gluconeogenesis, aminoacyl-tRNA biosynthesis, translation, metabolism, and cell signaling were detected in co-cultured <italic>H. pylori</italic>. This is consistent with our previous observation that in the presence of <italic>S. mitis, H. pylori</italic> was transformed to coccoid. Interestingly, phosphoglycerate kinase (PGK), a major enzyme used in glycolysis, was found in abundance in co-cultured <italic>S. mitis</italic> and this may have enhanced the survival of <italic>S. mitis</italic> in the multi-species microenvironment. On the other hand, thioredoxin (TrxA) and other redox-regulating enzymes of <italic>H. pylori</italic> were less abundant in co-culture possibly suggesting reduced oxidative stress. Oxidative stress plays an important role in tissue damage and carcinogenesis. Using the <italic>in vitro</italic> co-culture model, this study emphasized the possibility that pathogen-microbiota interaction may have a protective effect against <italic>H. pylori</italic>-associated carcinogenesis.</p></abstract>
<kwd-group><kwd><italic>Helicobacter pylori</italic></kwd>
<kwd><italic>Streptococcus mitis</italic></kwd>
<kwd>LC/Q-TOF mass spectrometry</kwd>
<kwd>phosphoglycerate kinase (PGK)</kwd>
<kwd>thioredoxin (TrxA)</kwd>
</kwd-group>
<counts>
<fig-count count="2"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="35"/>
<page-count count="8"/>
<word-count count="5108"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>The human stomach was considered to be microbiologically sterile before the successful culturing of <italic>Helicobacter pylori</italic> from gastric biopsy tissue (Marshall and Warren, <xref ref-type="bibr" rid="B24">1984</xref>). It was shown that gastritis and stomach ulcers in humans are caused by the Gram-negative, urease producing bacterium (Marshall and Warren, <xref ref-type="bibr" rid="B24">1984</xref>). Later, it also became clear that this bacterium is a major risk factor in the development of gastric adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma (Kusters et al., <xref ref-type="bibr" rid="B21">2006</xref>). In developing countries, 70&#x02013;90% of the population is infected with <italic>H. pylori</italic>; while in developed countries, the prevalence of <italic>H. pylori</italic> is 25&#x02013;50% (Solnick et al., <xref ref-type="bibr" rid="B30">2003</xref>; Obiageli and Ivan, <xref ref-type="bibr" rid="B25">2016</xref>).</p>
<p>Besides <italic>H. pylori</italic>, the human stomach can also contain transient oral, esophageal or intestinal bacteria and is highly dominated by <italic>Proteobacteria, Firmicutes, Actinobacteria</italic>, and <italic>Bacteroidetes</italic> (Dicksved et al., <xref ref-type="bibr" rid="B7">2007</xref>). These microorganisms may either be permanent members of the gastric microbiota but not picked up due to limitation of conventional microbiological culturing methods or may be in transit in the stomach (e.g., together with food intake). However, a change of the physiological conditions of the stomach, as occurs during acid-reducing drug therapy, corpus atrophy or gastric cancer, provides an opportunity for foreign microbes to enter and colonize the stomach (Dicksved et al., <xref ref-type="bibr" rid="B7">2007</xref>).</p>
<p>Streptococci are members of the normal intestinal flora of healthy individuals which exert antagonistic activities against many intestinal pathogens (Heczko et al., <xref ref-type="bibr" rid="B11">2006</xref>). A strong correlation was found between the presence of <italic>Streptococcus salivarius</italic> and <italic>H. pylori</italic> where 83% of the <italic>S. salivarius</italic> positive biopsies also harbored <italic>H. pylori</italic>. <italic>S. salivarius</italic> is known to have urease activity which creates a less acidic environment and could further enhance the survival and incidence of <italic>H. pylori</italic> (Ryan et al., <xref ref-type="bibr" rid="B28">2008</xref>). Hence, streptococci may potentially survive and develop in an acidic gastric environment as an indigenous microbiota of the gastric mucosa, which may in turn inhibit the colonization by <italic>H. pylori</italic> (Adolfsson et al., <xref ref-type="bibr" rid="B1">2004</xref>; Johnson-Henry et al., <xref ref-type="bibr" rid="B16">2004</xref>; Uziel et al., <xref ref-type="bibr" rid="B33">2004</xref>). In our previous studies, we have shown that <italic>Streptococcus mitis</italic> can be isolated from human gastric tissue biopsies (Khosravi et al., <xref ref-type="bibr" rid="B19">2014a</xref>) and co-culturing <italic>S. mitis</italic> and <italic>H. pylori</italic> released metabolites that induced <italic>H. pylori</italic> to transform into viable but non-culturable (VBNC) coccoidal form <italic>in vitro</italic> (Khosravi et al., <xref ref-type="bibr" rid="B18">2014b</xref>). On the other hand, culturability of <italic>S. mitis</italic> in the co-culture was enhanced. In this current paper, we completed our analysis by analyzing the changing protein profiles of <italic>H. pylori</italic> and <italic>S. mitis</italic> to understand the different response of the two bacterial species in a multi-species micro-environment. While it is not surprising that <italic>H. pylori</italic> changes to coccoid in a multi-species micro-environment, the enhancement of <italic>S. mitis</italic> survival capability deserve further investigation to determine any potential pathogenic role of this bacterium in the human gastric environment in the presence of <italic>H. pylori</italic>.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and methods</title>
<sec>
<title>Bacterial strains</title>
<p><italic>S. mitis</italic> ATCC 6249 and <italic>H. pylori</italic> NCTC 11637 (ATCC 43504) obtained from the American Type Culture Collection (ATCC, USA) were selected as model microorganisms to simulate interaction in a multispecies micro-environment. Culturing of both organisms was performed on chocolate agar plates supplemented with 7% horse blood and was incubated at 37&#x000B0;C in a humidified incubator with 10% CO<sub>2</sub> for 3 days (Khosravi et al., <xref ref-type="bibr" rid="B18">2014b</xref>).</p>
</sec>
<sec>
<title>Co-culture experiment</title>
<p>A bacterial co-culturing system was setup for this study in 12-well plates with a cell culture insert of 0.4 &#x003BC;m polyethylene terephathalate (PET) membrane (BD Biosciences, USA) that physically separate the two bacteria only allowing secreted compounds to penetrate as previously described (Khosravi et al., <xref ref-type="bibr" rid="B18">2014b</xref>). Briefly, for the co-culture assay, 3 days old <italic>H. pylori</italic> and 1 day old <italic>S. mitis</italic> from chocolate-agar plates were used to make a suspension of OD600 &#x0007E;0.02 (10<sup>6</sup>&#x02013;10<sup>7</sup> cfu/ml) and OD600 &#x0007E;0.008 (10<sup>5</sup>&#x02013;10<sup>6</sup> cfu/ml) respectively in an enrichment medium of Brain heart infusion broth (BHI) supplemented with 0.4% yeast extract and 1% &#x003B2;-cyclodextrin. An aliquot of 2 ml suspension of <italic>H. pylori</italic> was distributed in each well of the 12-well plates. An aliquot of 0.5 ml suspension of <italic>S. mitis</italic> was added to the insert. The cultures were incubated at 37&#x000B0;C in a humidified incubator with 10% CO<sub>2</sub> for 1&#x02013;4 days. Experiments were carried out as independent biological triplicates.</p>
</sec>
<sec>
<title>Protein extraction</title>
<p>The ProteoSpin detergent-free total protein isolation kit (Norgen Biotek, Canada) with the Halt protease and phosphatase inhibitors cocktail (Thermo Scientific, USA) was used for the isolation and purification of total protein from bacteria pellet according to the manufacturer&#x00027;s instructions. The lysates were subsequently treated with 10 mM dithiothreitol (DTT; Bio-Rad, USA) at 37&#x000B0;C for 10 min and alkylated with 55 mM iodoacetamide (IAA; Bio-Rad) for 30 min at room temperature. The proteins in the sample were digested with 1:50 (trypsin: protein) of MS-grade Pierce trypsin protease (Thermo Scientific, USA) at 37&#x000B0;C overnight. The samples were desalted using a Pierce C-18 spin column (Thermo Scientific, USA) and dried to completeness in a refrigerated CentriVap centrifugal vacuum concentrator (Labconco, USA) before mass spectrometry analysis.</p>
</sec>
<sec>
<title>Protein profiling by LC/Q-TOF MS system</title>
<p>Tryptic peptides were analyzed on the 1260 Infinity HPLC-Chip System coupled with the 6540 UHD Accurate-Mass Quadrupole Time-of-Flight (Q-TOF) LC/MS systems (Agilent, USA). For analysis, the injection volume was 2 &#x003BC;l of tryptic digest (200 ng/&#x003BC;l). The HPLC-Chip was the Large Capacity C18 Chip (G4240-6210), which comprised a 160 nL enrichment column and a 150 mm analytical column. HPLC-grade water with 0.1% formic acid and acetonitrile with 0.1% formic acid were used as mobile phases A and B respectively. HPLC-grade acetonitrile and formic acid were procured from Friendemann Schmidt (Australia) and Sigma (USA), respectively. Instrument settings were as described in Chan et al. (<xref ref-type="bibr" rid="B4">2015</xref>).</p>
</sec>
<sec>
<title>Data analysis</title>
<p>Mass spectrometric data were processed and analyzed using the Peaks software, version 7.5 (Bioinformatics Solutions Inc., Canada) for MS/MS-based identification and <italic>de novo</italic> sequencing. <italic>De novo</italic> sequencing was carried out with the default parameters, except that: (i) parent mass error tolerance was 1.5 Da, (ii) fragment mass error tolerance was 0.5 Da, (iii) trypsin as digestion enzyme, (iv) carbamidomethylation (&#x0002B;57.02 Da, C) as fixed modification, (v) oxidation (&#x0002B;15.99 Da, M) as variable modification, (vi) maximum variable post-translation modification allowed per peptide was three and (vii) <italic>H. pylori</italic> (strain NCTC 11637/ATCC 43504; 1633 proteins) and <italic>S. mitis</italic> (ATCC 6249; 1793 proteins) UniProtKB reference proteomes databases were used for identifications. Peptides were identified with PEAKS DB and filtered at 1% false discover rate (FDR). Proteins were filtered at 1 minimum unique peptide. Label-free quantification of protein abundances were estimated in each sample by correlation the average of the feature intensities of the three most highly responding peptides per protein.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>Statistical analyses were performed using the IBM SPSS version 21.0 software. One-way ANOVA and Two-tailed student&#x00027;s <italic>t</italic>-test were performed. <italic>P</italic>-value of &#x0003C;0.05 was considered significant.</p>
</sec>
</sec>
<sec id="s3">
<title>Results and discussion</title>
<p>A total of 1514 <italic>H. pylori</italic> and 1414 <italic>S. mitis</italic> proteins - identified based on &#x02212;logP &#x02265;20, &#x02265;1 unique peptide(s) (FDR &#x0003C;1%) and were detected in &#x02265;2 of the triplicates - in both mono- and co-cultures (day 1, 2, and 4) are presented as Venn diagrams (Figure <xref ref-type="fig" rid="F1">1</xref>). Complete list of proteins identified can be found in the Supplementary Materials with confidence of identification and peptide data.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><bold>Venn diagram of number of proteins <italic><bold>H. pylori</bold></italic> and <italic><bold>S. mitis</bold></italic> found in mono and co-cultures at day 1, 2, and 4</bold>.</p></caption>
<graphic xlink:href="fmicb-07-01462-g0001.tif"/>
</fig>
<p><italic>H. pylori</italic> proteins that were found to be significantly different between mono-cultured and co-cultured <italic>H. pylori</italic> were mapped to 12 and six biological pathways respectively (Table <xref ref-type="table" rid="T1">1</xref>). Proteins involve in RNA degradation, nucleotide excision repair, mismatch repair, and lipopolysaccharide (LPS) biosynthesis were relative more abundant in co-cultured <italic>H. pylori</italic>. On the other hand, proteins involve in citrate cycle, glycolysis/ gluconeogenesis, aminoacyl-tRNA biosynthesis, translation, metabolism, and cell signaling were less abundant in co-cultured <italic>H. pylori</italic>. This is consistent with the observation that in the presence of <italic>S. mitis, H. pylori</italic> was transformed to coccoid (Khosravi et al., <xref ref-type="bibr" rid="B18">2014b</xref>). <italic>H. pylori</italic> coccoid has been demonstrated to have low metabolic enzymes (FBA, EDD, AcnB, FumC, OorA, and ICD as shown in <bold>Table 2B</bold>) but proteins involved in DNA biosynthesis remained high (Loke et al., <xref ref-type="bibr" rid="B23">2016</xref>). Despite that <italic>H. pylori</italic> coccoid cannot be cultured <italic>in vitro</italic>, it has been reported that the coccoid had a stronger inhibitory effect on proliferation and weaker apoptotic effect than its spiral counterpart (Li et al., <xref ref-type="bibr" rid="B22">2013</xref>), which suggest that the coccoid may be an important factor in gastric cancer progression. However, contradictory to the earlier report (Loke et al., <xref ref-type="bibr" rid="B23">2016</xref>), proteins involve in epithelial cell signaling during <italic>H. pylori</italic> infection were reduced and those involved in LPS biosynthesis (Table <xref ref-type="table" rid="T1">1</xref>) were increased in <italic>H. pylori</italic> coccoid induced by co-culturing with <italic>S. mitis</italic>. These differences may highlight differences between <italic>H. pylori</italic> coccoids induced by various means (prolonged culturing vs. co-culturing with <italic>S. mitis</italic>) and age of coccoids (3 months old vs. 4 days old). Furthermore, the role of <italic>H. pylori</italic> coccoids in a multi-species environment and its impact on gastric pathogenesis has not been fully assessed.</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p><bold>KEGG pathway and GO enrichment analysis of <italic><bold>H. pylori</bold></italic> proteins in mono- and co-cultures using functional annotation tool of DAVID</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>Sample group</bold></th>
<th valign="top" align="left"><bold>Pathway</bold></th>
<th valign="top" align="center"><bold>Count</bold></th>
<th valign="top" align="center"><bold>Percentage</bold></th>
<th valign="top" align="left"><bold>Proteins</bold></th>
<th valign="top" align="center"><bold>Total</bold></th>
<th valign="top" align="center"><bold>Pop Hits</bold></th>
<th valign="top" align="center"><bold>Pop Total</bold></th>
<th valign="top" align="center"><bold>Fold Enrichment</bold></th>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><italic><bold>P</bold></italic><bold>-value</bold></th>
</tr>
<tr>
<th/>
<th/>
<th/>
<th/>
<th/>
<th/>
<th/>
<th/>
<th/>
<th valign="top" align="center"><bold>Bonferroni</bold></th>
<th valign="top" align="center"><bold>Benjamini</bold></th>
<th valign="top" align="center"><bold>FDR</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">HP</td>
<td valign="top" align="left">hpp00020:Citrate cycle (TCA cycle)</td>
<td valign="top" align="center">9</td>
<td valign="top" align="center">6.02</td>
<td valign="top" align="left">AcnB, PorD, OorB, GltA, OorA, OorC, PorB, FumC, ICD</td>
<td valign="top" align="center">67</td>
<td valign="top" align="center">15</td>
<td valign="top" align="center">2109</td>
<td valign="top" align="center">16.79</td>
<td valign="top" align="center">2.22E&#x02212;05</td>
<td valign="top" align="center">2.22E&#x02212;05</td>
<td valign="top" align="center">1.41E&#x02212;04</td>
</tr>
<tr>
<td valign="top" align="left">HP</td>
<td valign="top" align="left">hpj00970:Aminoacyl-tRNA biosynthesis</td>
<td valign="top" align="center">7</td>
<td valign="top" align="center">5.26</td>
<td valign="top" align="left">LeuS, ArgS, AspS, MetG, GatA, GLTX1, AlaS</td>
<td valign="top" align="center">67</td>
<td valign="top" align="center">25</td>
<td valign="top" align="center">2109</td>
<td valign="top" align="center">8.81</td>
<td valign="top" align="center">0.02</td>
<td valign="top" align="left">&#x0003C;0.01</td>
<td valign="top" align="center">0.10</td>
</tr>
<tr>
<td valign="top" align="left">HP</td>
<td valign="top" align="left">hpj00010:Glycolysis / Gluconeogenesis</td>
<td valign="top" align="center">6</td>
<td valign="top" align="center">4.51</td>
<td valign="top" align="left">PorD, FBA, PorB, GAP_2, ENO, JHP_1030</td>
<td valign="top" align="center">67</td>
<td valign="top" align="center">16</td>
<td valign="top" align="center">2109</td>
<td valign="top" align="center">11.80</td>
<td valign="top" align="center">0.02</td>
<td valign="top" align="left">&#x0003C;0.01</td>
<td valign="top" align="center">0.11</td>
</tr>
<tr>
<td valign="top" align="left">HP</td>
<td valign="top" align="left">hpj00230:Purine metabolism</td>
<td valign="top" align="center">6</td>
<td valign="top" align="center">3.76</td>
<td valign="top" align="left">JHP_1168, ADK, UreA, UreB, GuaB, NDK</td>
<td valign="top" align="center">67</td>
<td valign="top" align="center">34</td>
<td valign="top" align="center">2109</td>
<td valign="top" align="center">4.63</td>
<td valign="top" align="center">0.98</td>
<td valign="top" align="center">0.36</td>
<td valign="top" align="center">22.35</td>
</tr>
<tr>
<td valign="top" align="left">HP</td>
<td valign="top" align="left">hpj05120:Epithelial cell signaling in <italic>Helicobacter pylori</italic> infection</td>
<td valign="top" align="center">6</td>
<td valign="top" align="center">3.76</td>
<td valign="top" align="left">CagY, UreA, UreB, VacA, CagE, ORF15</td>
<td valign="top" align="center">67</td>
<td valign="top" align="center">34</td>
<td valign="top" align="center">2109</td>
<td valign="top" align="center">4.63</td>
<td valign="top" align="center">0.98</td>
<td valign="top" align="center">0.36</td>
<td valign="top" align="center">22.35</td>
</tr>
<tr>
<td valign="top" align="left">HP</td>
<td valign="top" align="left">hpp03010:Ribosome</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">3.76</td>
<td valign="top" align="left">RplI, RplN, RpsA, RplD, RplL</td>
<td valign="top" align="center">67</td>
<td valign="top" align="center">49</td>
<td valign="top" align="center">2109</td>
<td valign="top" align="center">3.21</td>
<td valign="top" align="center">0.10</td>
<td valign="top" align="center">0.67</td>
<td valign="top" align="center">56.63</td>
</tr>
<tr>
<td valign="top" align="left">HP</td>
<td valign="top" align="left">hpj00240:Pyrimidine metabolism</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">3.01</td>
<td valign="top" align="left">JHP_1168, NDK, TRXB_2, PyrF</td>
<td valign="top" align="center">67</td>
<td valign="top" align="center">35</td>
<td valign="top" align="center">2109</td>
<td valign="top" align="center">3.60</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0.70</td>
<td valign="top" align="center">70.95</td>
</tr>
<tr>
<td valign="top" align="left">HP</td>
<td valign="top" align="left">hpj00030:Pentose phosphate pathway</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">2.26</td>
<td valign="top" align="left">FBA, EDD, TktA</td>
<td valign="top" align="center">67</td>
<td valign="top" align="center">13</td>
<td valign="top" align="center">2109</td>
<td valign="top" align="center">7.26</td>
<td valign="top" align="center">0.10</td>
<td valign="top" align="center">0.67</td>
<td valign="top" align="center">54.023</td>
</tr>
<tr>
<td valign="top" align="left">HP</td>
<td valign="top" align="left">hpj00250:Alanine, aspartate and glutamate metabolism</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">2.26</td>
<td valign="top" align="left">GlmS, AspB, AspA</td>
<td valign="top" align="center">67</td>
<td valign="top" align="center">13</td>
<td valign="top" align="center">2109</td>
<td valign="top" align="center">7.26</td>
<td valign="top" align="center">0.10</td>
<td valign="top" align="center">0.67</td>
<td valign="top" align="center">54.023</td>
</tr>
<tr>
<td valign="top" align="left">HP</td>
<td valign="top" align="left">hpj00480:Glutathione metabolism</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">2.26</td>
<td valign="top" align="left">PepA, GGT, ICD</td>
<td valign="top" align="center">67</td>
<td valign="top" align="center">6</td>
<td valign="top" align="center">2109</td>
<td valign="top" align="center">15.74</td>
<td valign="top" align="center">0.93</td>
<td valign="top" align="center">0.28</td>
<td valign="top" align="center">15.46</td>
</tr>
<tr>
<td valign="top" align="left">HP</td>
<td valign="top" align="left">hpj00620:Pyruvate metabolism</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">2.26</td>
<td valign="top" align="left">PorD, PpsA, PorB</td>
<td valign="top" align="center">67</td>
<td valign="top" align="center">12</td>
<td valign="top" align="center">2109</td>
<td valign="top" align="center">7.87</td>
<td valign="top" align="center">0.10</td>
<td valign="top" align="center">0.65</td>
<td valign="top" align="center">48.72</td>
</tr>
<tr>
<td valign="top" align="left">HPc</td>
<td valign="top" align="left">hpj00240:Pyrimidine metabolism</td>
<td valign="top" align="center">6</td>
<td valign="top" align="center">13.95</td>
<td valign="top" align="left">PyrG, DnaN, TRXB_1, DnaX, RpoB, PNP</td>
<td valign="top" align="center">24</td>
<td valign="top" align="center">35</td>
<td valign="top" align="center">2109</td>
<td valign="top" align="center">15.06</td>
<td valign="top" align="left">&#x0003C;0.01</td>
<td valign="top" align="left">&#x0003C;0.01</td>
<td valign="top" align="center">0.03</td>
</tr>
<tr>
<td valign="top" align="left">HPc</td>
<td valign="top" align="left">hpj00230:Purine metabolism</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">11.63</td>
<td valign="top" align="left">GppA, DnaN, DnaX, RpoB, PNP</td>
<td valign="top" align="center">24</td>
<td valign="top" align="center">34</td>
<td valign="top" align="center">2109</td>
<td valign="top" align="center">12.92</td>
<td valign="top" align="center">0.03</td>
<td valign="top" align="left">&#x0003C;0.01</td>
<td valign="top" align="center">0.41</td>
</tr>
<tr>
<td valign="top" align="left">HPc</td>
<td valign="top" align="left">hpj03018:RNA degradation</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">9.30</td>
<td valign="top" align="left">RNJ, PPK, RHO, PNP</td>
<td valign="top" align="center">24</td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">2109</td>
<td valign="top" align="center">35.15</td>
<td valign="top" align="left">&#x0003C;0.01</td>
<td valign="top" align="left">&#x0003C;0.01</td>
<td valign="top" align="center">0.13</td>
</tr>
<tr>
<td valign="top" align="left">HPc</td>
<td valign="top" align="left">hpj03430:Mismatch repair</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">6.98</td>
<td valign="top" align="left">JHP_0847, DnaN, DnaX</td>
<td valign="top" align="center">24</td>
<td valign="top" align="center">15</td>
<td valign="top" align="center">2109</td>
<td valign="top" align="center">17.58</td>
<td valign="top" align="center">0.51</td>
<td valign="top" align="center">0.11</td>
<td valign="top" align="center">10.59</td>
</tr>
<tr>
<td valign="top" align="left">HPc</td>
<td valign="top" align="left">hpp00540:Lipopolysaccharide biosynthesis</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">6.98</td>
<td valign="top" align="left">KdsB, LpxA, LpxD</td>
<td valign="top" align="center">24</td>
<td valign="top" align="center">19</td>
<td valign="top" align="center">2109</td>
<td valign="top" align="center">13.88</td>
<td valign="top" align="center">0.67</td>
<td valign="top" align="center">0.15</td>
<td valign="top" align="center">16.32</td>
</tr>
<tr>
<td valign="top" align="left">HPc</td>
<td valign="top" align="left">hpj03420:Nucleotide excision repair</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">4.65</td>
<td valign="top" align="left">JHP_0847, UvrB</td>
<td valign="top" align="center">24</td>
<td valign="top" align="center">9</td>
<td valign="top" align="center">2109</td>
<td valign="top" align="center">19.53</td>
<td valign="top" align="center">0.10</td>
<td valign="top" align="center">0.55</td>
<td valign="top" align="center">63.38</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>KEGG, Kyoto Encyclopedia of Genes and Genomes; HP, H. pylori mono-culture; HPc, H. pylori and S. mitis co-culture. Count, the number of genes associated with this gene set; percentage, calculated by &#x0201C;gene associated with this gene set &#x0201C;/&#x0201D; total number of query genes;&#x0201D; total, the number of genes in query list mapped to any gene set in this ontology; pop hits, the number of genes annotated to this gene set on the background list; pop total, the number of genes on the background list mapped to any gene set in this ontology; fold enrichment, the ratio of the proportions on query genes and the background information which are associated with the gene set; Bonferroni, Bonferroni adjusted p-value; Benjamini, Benjamini adjusted p-value; FDR, FDR adjusted p-value</italic>.</p>
</table-wrap-foot>
</table-wrap>
<p>Among proteins identified, 27 proteins satisfied the criteria to be selected for label-free quantification analysis using the Peaks software. In contrast to 23 proteins that were significantly different in expression level between mono- and co-cultured <italic>H. pylori</italic> (<bold>Table 2B</bold>), only 4 proteins were found to be significantly different between mono- and co-cultured <italic>S. mitis</italic> (Table <xref ref-type="table" rid="T2">2A</xref>). This suggests that multi-species environment may have a greater impact on <italic>H. pylori</italic> than <italic>S. mitis</italic>.</p>
<table-wrap position="float" id="T2">
<label>Table 2A</label>
<caption><p><bold>List of <italic><bold>S. mitis</bold></italic> proteins with significant expression difference in mono- and co-cultures</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>Protein</bold></th>
<th valign="top" align="left"><bold>KEGG Pathway</bold></th>
<th valign="top" align="center"><bold>Unique peptide</bold></th>
<th valign="top" align="center"><bold>Avg. Mass</bold></th>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><italic><bold>S. mitis</bold></italic> <bold>monoculture</bold></th>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><italic><bold>S. mitis</bold></italic> <bold>co-culture</bold></th>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><italic><bold>P</bold></italic><bold>-value</bold></th>
</tr>
<tr>
<th/>
<th/>
<th/>
<th/>
<th valign="top" align="center"><bold>Day 1</bold></th>
<th valign="top" align="center"><bold>Day 2</bold></th>
<th valign="top" align="center"><bold>Day 4</bold></th>
<th valign="top" align="center"><bold>Day 1</bold></th>
<th valign="top" align="center"><bold>Day 2</bold></th>
<th valign="top" align="center"><bold>Day 4</bold></th>
<th valign="top" align="center"><bold>Day 1</bold></th>
<th valign="top" align="center"><bold>Day 2</bold></th>
<th valign="top" align="center"><bold>Day 4</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">50S ribosomal protein L13 (RplM)</td>
<td valign="top" align="left">smb03010:Ribosome</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">16143</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">6.82E&#x0002B;03</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">2.62E&#x02212;08</td>
</tr>
<tr>
<td valign="top" align="left">UPF0297 protein RN80_02805</td>
<td valign="top" align="left">&#x02013;</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">10227</td>
<td valign="top" align="center">5.15E&#x0002B;02</td>
<td valign="top" align="center">2.78E&#x0002B;02</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1.73E&#x0002B;03</td>
<td valign="top" align="center">1.77E&#x0002B;03</td>
<td valign="top" align="center">8.30E&#x0002B;02</td>
<td valign="top" align="center">0.015</td>
<td valign="top" align="center">7.51E&#x02212;04</td>
<td valign="top" align="center">&#x0003E;0.05</td>
</tr>
<tr>
<td valign="top" align="left">Phosphocarrier protein HPr (PtsH)</td>
<td valign="top" align="left">&#x02013;</td>
<td valign="top" align="center">7</td>
<td valign="top" align="center">8939</td>
<td valign="top" align="center">3.50E&#x0002B;04</td>
<td valign="top" align="center">9.07E&#x0002B;03</td>
<td valign="top" align="center">1.25E&#x0002B;05</td>
<td valign="top" align="center">4.52E&#x0002B;03</td>
<td valign="top" align="center">3.76E&#x0002B;04</td>
<td valign="top" align="center">1.91E&#x0002B;03</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">0.029</td>
<td valign="top" align="center">0.029</td>
</tr>
<tr>
<td valign="top" align="left">Phosphoglycerate kinase (Pgk)</td>
<td valign="top" align="left">smb00010:Glycolysis/Gluconeogenesis</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">41978</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1.01E&#x0002B;03</td>
<td valign="top" align="center">8.57E&#x0002B;02</td>
<td valign="top" align="center">7.03E&#x0002B;01</td>
<td valign="top" align="center">0.028</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">&#x0003E;0.05</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Among the differentially expressed proteins, phosphoglycerate kinase (PGK), which is required for ATP generation in both the glycolytic pathway of aerobes and the fermentation process of anaerobes (Yoshida and Tani, <xref ref-type="bibr" rid="B35">1983</xref>), was only expressed by co-cultured <italic>S. mitis</italic> (Table <xref ref-type="table" rid="T2">2A</xref> and Figure <xref ref-type="fig" rid="F2">2A</xref>). In addition, PGK is one of the predominant surface-associated proteins of streptococci, such as <italic>S. oralis</italic> (Wilkins et al., <xref ref-type="bibr" rid="B34">2003</xref>) and group B streptococci (Hughes et al., <xref ref-type="bibr" rid="B14">2002</xref>). Interestingly, sera directed against PGK was shown to protect neonatal animals from <italic>S. agalactiae</italic> infection suggesting that this protein may be essential for multiplication or adhesion of streptococci <italic>in vivo</italic> (Hughes et al., <xref ref-type="bibr" rid="B14">2002</xref>). The expression of <italic>S. mitis</italic> PGK in the presence of <italic>H. pylori</italic> might have contributed to the enhanced survival of <italic>S. mitis</italic>, which was demonstrated earlier by our group (Khosravi et al., <xref ref-type="bibr" rid="B18">2014b</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p><bold>Relative abundance of (A) PGK and (B) TrxA proteins in mono- and co-cultures</bold>. <sup>&#x0002A;</sup>Denote statistical significant differences with <italic>p</italic>-value &#x0003D; 0.028 (PGK) and &#x0003C;0.001 (TrxA) compared between mono- and co-cultures by 2-tailed one-way ANOVA.</p></caption>
<graphic xlink:href="fmicb-07-01462-g0002.tif"/>
</fig>
<p>Consistent with the reduction in abundance of enzymes involve in citrate cycle detected in the co-cultured <italic>H. pylori</italic> (Table <xref ref-type="table" rid="T1">1</xref>), the expression of citrate cycle enzymes (AcnB, FumC, OorA, and ICD) were also found to be lower in co-cultured <italic>H. pylori</italic> (Table <xref ref-type="table" rid="T3">2B</xref>), The citrate cycle is most sensitive to reactive oxygen species (ROS; Janero and Hreniuk, <xref ref-type="bibr" rid="B15">1996</xref>). Thus, reduced level of expression of citrate cycle enzyme may indicate reduced oxidative stress response of <italic>H. pylori</italic> in the presence of <italic>S. mitis</italic>. This viewpoint is further supported by reduced expression of glutathione metabolism enzymes (ICD and PepA), thioredoxin (TrxA), flavodoxin (FldA), and thiol peroxidases (TPX and TsaA) in co-cultured <italic>H. pylori</italic>.</p>
<table-wrap position="float" id="T3">
<label>Table 2B</label>
<caption><p><bold>List of <italic><bold>H. pylori</bold></italic> proteins with significant expression difference in mono- and co-cultures</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>Protein</bold></th>
<th valign="top" align="left"><bold>KEGG Pathway</bold></th>
<th valign="top" align="center"><bold>Unique peptide</bold></th>
<th valign="top" align="center"><bold>Avg. Mass</bold></th>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><italic><bold>H. pylori</bold></italic> <bold>monoculture</bold></th>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><italic><bold>H. pylori</bold></italic> <bold>co-culture</bold></th>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><italic><bold>P</bold></italic><bold>-value</bold></th>
</tr>
<tr>
<th/>
<th/>
<th/>
<th/>
<th valign="top" align="center"><bold>Day 1</bold></th>
<th valign="top" align="center"><bold>Day 2</bold></th>
<th valign="top" align="center"><bold>Day 4</bold></th>
<th valign="top" align="center"><bold>Day 1</bold></th>
<th valign="top" align="center"><bold>Day 2</bold></th>
<th valign="top" align="center"><bold>Day 4</bold></th>
<th valign="top" align="center"><bold>Day 1</bold></th>
<th valign="top" align="center"><bold>Day 2</bold></th>
<th valign="top" align="center"><bold>Day 4</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">JHP_0156</td>
<td valign="top" align="left">&#x02013;</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">27461</td>
<td valign="top" align="center">2.88E&#x0002B;02</td>
<td valign="top" align="center">6.69E&#x0002B;02</td>
<td valign="top" align="center">1.74E&#x0002B;02</td>
<td valign="top" align="center">1.21E&#x0002B;01</td>
<td valign="top" align="center">3.00E&#x0002B;01</td>
<td valign="top" align="center">3.67E&#x0002B;00</td>
<td valign="top" align="center">3.16E&#x02212;06</td>
<td valign="top" align="center">8.92E&#x02212;05</td>
<td valign="top" align="center">&#x0003E;0.05</td>
</tr>
<tr>
<td valign="top" align="left">Fructose-bisphosphate aldolase (FBA)</td>
<td valign="top" align="left">hpj00010:Glycolysis / Gluconeogenesis;<break/>hpj00030:Pentose phosphate pathway</td>
<td valign="top" align="center">12</td>
<td valign="top" align="center">33798</td>
<td valign="top" align="center">3.43E&#x0002B;02</td>
<td valign="top" align="center">6.43E&#x0002B;01</td>
<td valign="top" align="center">1.23E&#x0002B;04</td>
<td valign="top" align="center">9.77E&#x0002B;01</td>
<td valign="top" align="center">3.07E&#x0002B;00</td>
<td valign="top" align="center">4.73E&#x0002B;00</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">0.004</td>
</tr>
<tr>
<td valign="top" align="left">Phosphogluconate dehydratase (EDD)</td>
<td valign="top" align="left">hpj00030:Pentose phosphate pathway</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">66603</td>
<td valign="top" align="center">6.80E&#x0002B;02</td>
<td valign="top" align="center">8.46E&#x0002B;01</td>
<td valign="top" align="center">3.02E&#x0002B;03</td>
<td valign="top" align="center">1.93E&#x0002B;01</td>
<td valign="top" align="center">8.37E&#x0002B;00</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">6.19E&#x02212;05</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">0.008</td>
</tr>
<tr>
<td valign="top" align="left">Aconitate hydratase (AcnB)</td>
<td valign="top" align="left">hpj00020:Citrate cycle (TCA cycle)</td>
<td valign="top" align="center">11</td>
<td valign="top" align="center">92742</td>
<td valign="top" align="center">1.05E&#x0002B;03</td>
<td valign="top" align="center">2.02E&#x0002B;03</td>
<td valign="top" align="center">4.26E&#x0002B;03</td>
<td valign="top" align="center">5.37E&#x0002B;01</td>
<td valign="top" align="center">7.87E&#x0002B;01</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0.046</td>
<td valign="top" align="center">8.61E&#x02212;04</td>
<td valign="top" align="center">1.72E&#x02212;04</td>
</tr>
<tr>
<td valign="top" align="left">Fumarase (FumC)</td>
<td valign="top" align="left">hpp00020:Citrate cycle (TCA cycle)</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">50920</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1.98E&#x0002B;03</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">0.026</td>
</tr>
<tr>
<td valign="top" align="left">2-Oxoglutarate oxidoreductase subunit A (OorA)</td>
<td valign="top" align="left">hpp00020:Citrate cycle (TCA cycle)</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">41573</td>
<td valign="top" align="center">5.16E&#x0002B;02</td>
<td valign="top" align="center">5.96E&#x0002B;01</td>
<td valign="top" align="center">2.94E&#x0002B;03</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">0.025</td>
</tr>
<tr>
<td valign="top" align="left">Isocitrate dehydrogenase (ICD)</td>
<td valign="top" align="left">hpj00480:Glutathione metabolism;<break/>hpp00020:Citrate cycle (TCA cycle)</td>
<td valign="top" align="center">7</td>
<td valign="top" align="center">47462</td>
<td valign="top" align="center">6.92E&#x0002B;02</td>
<td valign="top" align="center">7.67E&#x0002B;02</td>
<td valign="top" align="center">1.76E&#x0002B;03</td>
<td valign="top" align="center">9.23E&#x0002B;01</td>
<td valign="top" align="center">3.06E&#x0002B;00</td>
<td valign="top" align="center">0.00E&#x0002B;00</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">9.20E&#x02212;04</td>
<td valign="top" align="center">&#x0003E;0.05</td>
</tr>
<tr>
<td valign="top" align="left">Aminopeptidase (PepA)</td>
<td valign="top" align="left">hpj00480:Glutathione metabolism</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">54612</td>
<td valign="top" align="center">1.40E&#x0002B;02</td>
<td valign="top" align="center">2.56E&#x0002B;01</td>
<td valign="top" align="center">1.63E&#x0002B;03</td>
<td valign="top" align="center">3.04E&#x0002B;01</td>
<td valign="top" align="center">2.71E&#x0002B;01</td>
<td valign="top" align="center">3.33E&#x0002B;01</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">0.002</td>
</tr>
<tr>
<td valign="top" align="left">Thiol peroxidase (TPX)</td>
<td valign="top" align="left">K11065 thiol peroxidase, atypical 2-Cys peroxiredoxin [EC:1.11.1.15]</td>
<td valign="top" align="center">6</td>
<td valign="top" align="center">18262</td>
<td valign="top" align="center">1.77E&#x0002B;03</td>
<td valign="top" align="center">5.40E&#x0002B;02</td>
<td valign="top" align="center">2.90E&#x0002B;03</td>
<td valign="top" align="center">1.26E&#x0002B;02</td>
<td valign="top" align="center">1.61E&#x0002B;02</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">0.003</td>
</tr>
<tr>
<td valign="top" align="left">Probable peroxiredoxin (TsaA)</td>
<td valign="top" align="left">K03386 peroxiredoxin (alkyl hydroperoxide reductase subunit C) [EC:1.11.1.15]; Exosome [BR:hpj04147]</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">22259</td>
<td valign="top" align="center">1.11E&#x0002B;03</td>
<td valign="top" align="center">6.15E&#x0002B;02</td>
<td valign="top" align="center">3.51E&#x0002B;03</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0.007</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">0.036</td>
</tr>
<tr>
<td valign="top" align="left">Thioredoxin (TrxA)</td>
<td valign="top" align="left">K03671 thioredoxin 1; Chaperones and folding catalysts [BR:hpj03110]</td>
<td valign="top" align="center">9</td>
<td valign="top" align="center">11855</td>
<td valign="top" align="center">1.71E&#x0002B;03</td>
<td valign="top" align="center">8.88E&#x0002B;02</td>
<td valign="top" align="center">1.24E&#x0002B;04</td>
<td valign="top" align="center">1.12E&#x0002B;03</td>
<td valign="top" align="center">9.47E&#x0002B;02</td>
<td valign="top" align="center">5.78E&#x0002B;02</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">9.98E&#x02212;05</td>
</tr>
<tr>
<td valign="top" align="left">Flavodoxin (FldA)</td>
<td valign="top" align="left">K03839 flavodoxin I</td>
<td valign="top" align="center">9</td>
<td valign="top" align="center">17473</td>
<td valign="top" align="center">8.38E&#x0002B;03</td>
<td valign="top" align="center">4.88E&#x0002B;03</td>
<td valign="top" align="center">3.17E&#x0002B;04</td>
<td valign="top" align="center">3.25E&#x0002B;03</td>
<td valign="top" align="center">1.66E&#x0002B;03</td>
<td valign="top" align="center">6.83E&#x0002B;01</td>
<td valign="top" align="center">0.003</td>
<td valign="top" align="center">0.028</td>
<td valign="top" align="center">2.25E&#x02212;05</td>
</tr>
<tr>
<td valign="top" align="left">JHP_0216</td>
<td valign="top" align="left">K03981 thiol:disulfide interchange protein DsbC [EC:5.3.4.1]; Chaperones and folding catalysts [BR:hpj03110]; Secretion system [BR:hpj02044]</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">29490</td>
<td valign="top" align="center">2.82E&#x0002B;02</td>
<td valign="top" align="center">2.11E&#x0002B;02</td>
<td valign="top" align="center">5.16E&#x0002B;03</td>
<td valign="top" align="center">6.35E&#x0002B;01</td>
<td valign="top" align="center">1.31E&#x0002B;02</td>
<td valign="top" align="center">4.10E&#x0002B;01</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">0.009</td>
</tr>
<tr>
<td valign="top" align="left">70kDa chaperone (DnaK)</td>
<td valign="top" align="left">hpj03018:RNA degradation</td>
<td valign="top" align="center">9</td>
<td valign="top" align="center">67122</td>
<td valign="top" align="center">3.03E&#x0002B;03</td>
<td valign="top" align="center">3.70E&#x0002B;03</td>
<td valign="top" align="center">4.75E&#x0002B;03</td>
<td valign="top" align="center">3.18E&#x0002B;02</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">2.15E&#x02212;04</td>
<td valign="top" align="center">0.032</td>
<td valign="top" align="center">0.019</td>
</tr>
<tr>
<td valign="top" align="left">JHP_0301</td>
<td valign="top" align="left">K07226 heme iron utilization protein</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">28584</td>
<td valign="top" align="center">5.35E&#x0002B;01</td>
<td valign="top" align="center">2.01E&#x0002B;01</td>
<td valign="top" align="center">1.44E&#x0002B;03</td>
<td valign="top" align="center">4.83E&#x0002B;00</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">0.037</td>
</tr>
<tr>
<td valign="top" align="left">Response regulator (CheY)</td>
<td valign="top" align="left">hpj02020:Two-component system;<break/>hpj02030:Bacterial chemotaxis</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">13926</td>
<td valign="top" align="center">5.01E&#x0002B;02</td>
<td valign="top" align="center">1.09E&#x0002B;03</td>
<td valign="top" align="center">2.79E&#x0002B;03</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">0.020</td>
</tr>
<tr>
<td valign="top" align="left">Urease subunit B (UreB)</td>
<td valign="top" align="left">hpj05120:Epithelial cell signaling in <italic>Helicobacter pylori</italic> infection;<break/>hpj00230:Purine metabolism;<break/>hpj00220:Arginine biosynthesis</td>
<td valign="top" align="center">8</td>
<td valign="top" align="center">61684</td>
<td valign="top" align="center">4.21E&#x0002B;03</td>
<td valign="top" align="center">1.30E&#x0002B;03</td>
<td valign="top" align="center">7.23E&#x0002B;03</td>
<td valign="top" align="center">1.04E&#x0002B;02</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">6.49E&#x02212;04</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">2.39E&#x02212;04</td>
</tr>
<tr>
<td valign="top" align="left">Urease subunit A (UreA)</td>
<td valign="top" align="left">hpj05120:Epithelial cell signaling in <italic>Helicobacter pylori</italic> infection;<break/>hpj00230:Purine metabolism;<break/>hpj00791:Atrazine degradation</td>
<td valign="top" align="center">7</td>
<td valign="top" align="center">26568</td>
<td valign="top" align="center">2.34E&#x0002B;03</td>
<td valign="top" align="center">4.23E&#x0002B;03</td>
<td valign="top" align="center">5.42E&#x0002B;03</td>
<td valign="top" align="center">1.79E&#x0002B;02</td>
<td valign="top" align="center">7.40E&#x0002B;01</td>
<td valign="top" align="center">7.83E&#x0002B;00</td>
<td valign="top" align="center">0.018</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">0.025</td>
</tr>
<tr>
<td valign="top" align="left">50S Ribosomal protein L7/L12 (RplL)</td>
<td valign="top" align="left">hpp03010:Ribosome</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">13314</td>
<td valign="top" align="center">3.11E&#x0002B;03</td>
<td valign="top" align="center">1.19E&#x0002B;03</td>
<td valign="top" align="center">3.05E&#x0002B;03</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1.90E&#x02212;04</td>
<td valign="top" align="center">0.036</td>
<td valign="top" align="center">0.003</td>
</tr>
<tr>
<td valign="top" align="left">Elongation factor Ts (TSF)</td>
<td valign="top" align="left">Translation factors [BR:hpj03012]</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">39859</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1.44E&#x0002B;02</td>
<td valign="top" align="center">3.55E&#x0002B;02</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">6.01E&#x02212;04</td>
</tr>
<tr>
<td valign="top" align="left">Elongation factor G (FusA)</td>
<td valign="top" align="left">Translation factors [BR:hpj03012]</td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">77127</td>
<td valign="top" align="center">3.02E&#x0002B;02</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">2.20E&#x0002B;03</td>
<td valign="top" align="center">3.07E&#x0002B;02</td>
<td valign="top" align="center">4.50E&#x0002B;01</td>
<td valign="top" align="center">9.61E&#x0002B;01</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">0.027</td>
<td valign="top" align="center">0.002</td>
</tr>
<tr>
<td valign="top" align="left">Elongation factor Tu (TUF)</td>
<td valign="top" align="left">Translation factors [BR:hpj03012]; Exosome [BR:hpj04147]</td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">43730</td>
<td valign="top" align="center">4.51E&#x0002B;03</td>
<td valign="top" align="center">1.19E&#x0002B;03</td>
<td valign="top" align="center">9.60E&#x0002B;03</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">8.83E&#x0002B;00</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0.002</td>
<td valign="top" align="center">0.036</td>
<td valign="top" align="center">0.014</td>
</tr>
<tr>
<td valign="top" align="left">GTP-binding protein TypA/BipA homolog (TypA)</td>
<td valign="top" align="left">K06207 GTP-binding protein</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">66649</td>
<td valign="top" align="center">9.77E&#x0002B;01</td>
<td valign="top" align="center">2.93E&#x0002B;01</td>
<td valign="top" align="center">2.45E&#x0002B;03</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">6.23E&#x0002B;00</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">&#x0003E;0.05</td>
<td valign="top" align="center">0.026</td>
<td valign="top" align="center">0.023</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The expression of thioredoxin (TrxA), a small redox-regulating protein that is involved in maintaining the thiol/ disulfide balance in both prokaryotes and eukaryotes (Holmgren, <xref ref-type="bibr" rid="B13">1985</xref>), was significantly reduced in 4 days old co-cultured <italic>H. pylori</italic> (Figure <xref ref-type="fig" rid="F2">2B</xref>). This protein is essential for protecting bacteria, such as <italic>Bacillus subtilis</italic> (Scharf et al., <xref ref-type="bibr" rid="B29">1998</xref>; Uziel et al., <xref ref-type="bibr" rid="B33">2004</xref>), <italic>Bacteroides fragilis</italic> (Tally et al., <xref ref-type="bibr" rid="B31">1975</xref>; Rolfe et al., <xref ref-type="bibr" rid="B27">1997</xref>) and <italic>Salmonella</italic> species (Bjur et al., <xref ref-type="bibr" rid="B2">2006</xref>), against oxidative stress for survival and replication. Interestingly, TrxA is also highly expressed in many cancers, including lung (Kim et al., <xref ref-type="bibr" rid="B20">2003</xref>), cervix (Hedley et al., <xref ref-type="bibr" rid="B12">2004</xref>), pancreatic (Han et al., <xref ref-type="bibr" rid="B10">2002</xref>), colorectal (Raffel et al., <xref ref-type="bibr" rid="B26">2003</xref>), hepatocellular carcinomas (Choi et al., <xref ref-type="bibr" rid="B5">2002</xref>), gastric carcinomas (Grogan et al., <xref ref-type="bibr" rid="B9">2000</xref>) and breast cancer (Cha et al., <xref ref-type="bibr" rid="B3">2009</xref>). TrxA has been postulated to contribute toward cancer progression by playing crucial roles in maintaining cellular redox homeostasis and cell survival (Trachootham et al., <xref ref-type="bibr" rid="B32">2008</xref>). Up-regulation of TrxA and related proteins has been postulated to present a dynamic redox change to drive proliferation and malignant progression of tumors (Karlenius and Tonissen, <xref ref-type="bibr" rid="B17">2010</xref>). In the presence of <italic>S. mitis</italic>, the expression of <italic>H. pylori</italic> TrxA was reduced suggesting that <italic>S. mitis</italic> may potentially reduce the risk of <italic>H. pylori</italic>-associated gastric cancer development and/ or progression in the human stomach.</p>
<p>Alkylhydroperoxide reductase of <italic>H. pylori</italic>, which protects the bacterium from a hyperoxidative environment by reduction of toxic organic hydroperoxides, has been shown to function as a molecular chaperone for prevention of protein misfolding under oxidative stress (Chuang et al., <xref ref-type="bibr" rid="B6">2006</xref>). This study highlights the importance of translation (elongation factors) and protein folding (chaperones) to <italic>H. pylori</italic> in response to oxidative stress. Thus, low level of expression of chaperones, such as TrxA, JHP_0216 and DnaK (aka 70 kDa chaperone; Table <xref ref-type="table" rid="T3">2B</xref>), implies relatively low oxidative stress level in co-culture <italic>H. pylori</italic>. It has been shown that both bacterial factors and host inflammatory response causes oxidative stress on the gastric epithelium during <italic>H. pylori</italic> infection that may lead to apoptosis and tissue damage (Ding et al., <xref ref-type="bibr" rid="B8">2007</xref>). Thus, low oxidative stress confers by <italic>H. pylori</italic> in a multi-species environment can be expected to be less pathogenic.</p>
<p>In conclusion, using <italic>S. mitis</italic> and <italic>H. pylori</italic> as model organism, data from this <italic>in vitro</italic> study suggest that in a multi-species setting, <italic>S. mitis</italic> may be able to benefit from cross-talking with <italic>H. pylori</italic> to enhancing its survival in the adverse gastric environment. Simultaneously, <italic>S. mitis</italic> may protect <italic>H. pylori</italic> from excessive oxidative stress. This <italic>in vitro</italic> co-culture model emphasizes the possibility that inter-species interaction may protect the host against bacterial-associated pathogenesis and carcinogenesis. However, this study is preliminary and the human gastric environment is highly complex and dynamic. Therefore, more evidences are required in order to fully understand the implication of <italic>H. pylori</italic>-gastric microbiota crosstalk and its impact on the development of gastroduodenal diseases in human.</p>
</sec>
<sec id="s4">
<title>Author contributions</title>
<p>Conceived and designed the experiments: YK, MFL, KLG, JV. Performed the experiments: YK. Analyzed the data: YK, MFL.</p>
</sec>
<sec>
<title>Funding</title>
<p>University of Malaya-Ministry of Higher Education (UM-MOHE) High Impact Research (HIR) grant (reference UM.C/625/1/HIR/MOHE/CHAN-02; account no. A000002-50001, &#x0201C;Molecular Genetics&#x0201D;).</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<sec sec-type="supplementary-material" id="s5">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fmicb.2016.01462">http://journal.frontiersin.org/article/10.3389/fmicb.2016.01462</ext-link></p>
<supplementary-material xlink:href="DataSheet1.XLSX" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adolfsson</surname> <given-names>O.</given-names></name> <name><surname>Meydani</surname> <given-names>S. N.</given-names></name> <name><surname>Russell</surname> <given-names>R. M.</given-names></name></person-group> (<year>2004</year>). <article-title>Yogurt and gut function</article-title>. <source>Am. J. Clin. Nutr.</source> <volume>80</volume>, <fpage>245</fpage>&#x02013;<lpage>256</lpage>. <pub-id pub-id-type="pmid">15277142</pub-id></citation>
</ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bjur</surname> <given-names>E.</given-names></name> <name><surname>Eriksson-Ygberg</surname> <given-names>S.</given-names></name> <name><surname>&#x000C5;slund</surname> <given-names>F.</given-names></name> <name><surname>Rhen</surname> <given-names>M.</given-names></name></person-group> (<year>2006</year>). <article-title>Thioredoxin promotes intracellular replication and virulence of <italic>Salmonella enterica</italic> serovar Typhimurium</article-title>. <source>Infect. Immun.</source> <volume>74</volume>, <fpage>5140</fpage>&#x02013;<lpage>5151</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00449-06</pub-id><pub-id pub-id-type="pmid">16926406</pub-id></citation>
</ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname> <given-names>M. K.</given-names></name> <name><surname>Suh</surname> <given-names>K. H.</given-names></name> <name><surname>Kim</surname> <given-names>I. H.</given-names></name></person-group> (<year>2009</year>). <article-title>Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma</article-title>. <source>J. Exp. Clin. Cancer Res.</source> <volume>28</volume>:<fpage>93</fpage>. <pub-id pub-id-type="doi">10.1186/1756-9966-28-93</pub-id><pub-id pub-id-type="pmid">19566940</pub-id></citation>
</ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname> <given-names>K. G.</given-names></name> <name><surname>Loke</surname> <given-names>M. F.</given-names></name> <name><surname>Ong</surname> <given-names>B. L.</given-names></name> <name><surname>Wong</surname> <given-names>Y. L.</given-names></name> <name><surname>Hong</surname> <given-names>K. W.</given-names></name> <name><surname>Tan</surname> <given-names>K. H.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Multiphasic strain differentiation of atypical mycobacteria from elephant trunk wash</article-title>. <source>Peer J.</source> <volume>3</volume>:<fpage>e1367</fpage>. <pub-id pub-id-type="doi">10.7717/peerj.1367</pub-id><pub-id pub-id-type="pmid">26587340</pub-id></citation>
</ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname> <given-names>J. H.</given-names></name> <name><surname>Kim</surname> <given-names>T. N.</given-names></name> <name><surname>Kim</surname> <given-names>S.</given-names></name> <name><surname>Baek</surname> <given-names>S. H.</given-names></name> <name><surname>Kim</surname> <given-names>J. H.</given-names></name> <name><surname>Lee</surname> <given-names>S. R.</given-names></name> <etal/></person-group>. (<year>2002</year>). <article-title>Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinomas</article-title>. <source>Anticancer Res.</source> <volume>22</volume>, <fpage>3331</fpage>&#x02013;<lpage>3335</lpage>. <pub-id pub-id-type="pmid">12530083</pub-id></citation>
</ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chuang</surname> <given-names>M. H.</given-names></name> <name><surname>Wu</surname> <given-names>M. S.</given-names></name> <name><surname>Lo</surname> <given-names>W. L.</given-names></name> <name><surname>Lin</surname> <given-names>J. T.</given-names></name> <name><surname>Wong</surname> <given-names>C. H.</given-names></name> <name><surname>Chiou</surname> <given-names>S. H.</given-names></name></person-group> (<year>2006</year>). <article-title>The antioxidant protein alkylhydroperoxide reductase of <italic>Helicobacter pylori</italic> switches from a peroxide reductase to a molecular chaperone function</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>103</volume>, <fpage>2552</fpage>&#x02013;<lpage>2557</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0510770103</pub-id><pub-id pub-id-type="pmid">16481626</pub-id></citation>
</ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dicksved</surname> <given-names>J.</given-names></name> <name><surname>Fl&#x000F6;oistrup</surname> <given-names>H.</given-names></name> <name><surname>Bergstr&#x000F6;m</surname> <given-names>A.</given-names></name> <name><surname>Rosenquist</surname> <given-names>M.</given-names></name> <name><surname>Pershagen</surname> <given-names>G.</given-names></name> <name><surname>Scheynius</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Molecular fingerprinting of the fecal microbiota of children raised according to different lifestyles</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>73</volume>, <fpage>2284</fpage>&#x02013;<lpage>2289</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.02223-06</pub-id><pub-id pub-id-type="pmid">17293501</pub-id></citation>
</ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname> <given-names>S. Z.</given-names></name> <name><surname>Minohara</surname> <given-names>Y.</given-names></name> <name><surname>Fan</surname> <given-names>X. J.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Reyes</surname> <given-names>V. E.</given-names></name> <name><surname>Patel</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title><italic>Helicobacter pylori</italic> infection induces oxidative stress and programmed cell death in human gastric epithelial cells</article-title>. <source>Infect. Immun.</source> <volume>75</volume>, <fpage>4030</fpage>&#x02013;<lpage>4039</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00172-07</pub-id><pub-id pub-id-type="pmid">17562777</pub-id></citation>
</ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grogan</surname> <given-names>T. M.</given-names></name> <name><surname>Fenoglio-Prieser</surname> <given-names>C.</given-names></name> <name><surname>Zeheb</surname> <given-names>R.</given-names></name> <name><surname>Bellamy</surname> <given-names>W.</given-names></name> <name><surname>Frutiger</surname> <given-names>Y.</given-names></name> <name><surname>Vela</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>2000</year>). <article-title>Thioredoxin, a putative oncogene product, is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survival</article-title>. <source>Hum. Pathol.</source> <volume>31</volume>, <fpage>475</fpage>&#x02013;<lpage>481</lpage>. <pub-id pub-id-type="doi">10.1053/hp.2000.6546</pub-id><pub-id pub-id-type="pmid">10821495</pub-id></citation>
</ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>H.</given-names></name> <name><surname>Bearss</surname> <given-names>D. J.</given-names></name> <name><surname>Browne</surname> <given-names>L. W.</given-names></name> <name><surname>Calaluce</surname> <given-names>R.</given-names></name> <name><surname>Nagle</surname> <given-names>R. B.</given-names></name> <name><surname>Von Hoff</surname> <given-names>D. D.</given-names></name></person-group> (<year>2002</year>). <article-title>Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray</article-title>. <source>Cancer Res.</source> <volume>62</volume>, <fpage>2890</fpage>&#x02013;<lpage>2896</lpage>. <pub-id pub-id-type="pmid">12019169</pub-id></citation>
</ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heczko</surname> <given-names>P. B.</given-names></name> <name><surname>Strus</surname> <given-names>M.</given-names></name> <name><surname>Kochan</surname> <given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title>Critical evaluation of probiotic activity of lactic acid bacteria and their effects</article-title>. <source>J. Physiol. Pharmacol.</source> <volume>9</volume>, <fpage>5</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="pmid">17242483</pub-id></citation>
</ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hedley</surname> <given-names>D.</given-names></name> <name><surname>Pintilie</surname> <given-names>M.</given-names></name> <name><surname>Woo</surname> <given-names>J.</given-names></name> <name><surname>Nicklee</surname> <given-names>T.</given-names></name> <name><surname>Morrison</surname> <given-names>A.</given-names></name> <name><surname>Birle</surname> <given-names>D.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>Up-regulation of the redox mediators thioredoxin and apurinic/ apyrimidinic excision (APE)/Ref-1 in hypoxic microregions of invasive cervical carcinomas, mapped using multispectral, wide-field fluorescence image analysis</article-title>. <source>Am. J. Pathol.</source> <volume>164</volume>, <fpage>557</fpage>&#x02013;<lpage>565</lpage>. <pub-id pub-id-type="doi">10.1016/s0002-9440(10)63145-8</pub-id><pub-id pub-id-type="pmid">14742261</pub-id></citation>
</ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holmgren</surname> <given-names>A.</given-names></name></person-group> (<year>1985</year>). <article-title>Thioredoxin</article-title>. <source>Annu. Rev. Biochem.</source> <volume>54</volume>, <fpage>237</fpage>&#x02013;<lpage>271</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.bi.54.070185.001321</pub-id><pub-id pub-id-type="pmid">27026037</pub-id></citation>
</ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname> <given-names>M. J.</given-names></name> <name><surname>Moore</surname> <given-names>J. C.</given-names></name> <name><surname>Lane</surname> <given-names>J. D.</given-names></name> <name><surname>Wilson</surname> <given-names>R.</given-names></name> <name><surname>Pribul</surname> <given-names>P. K.</given-names></name> <name><surname>Younes</surname> <given-names>Z. N.</given-names></name> <etal/></person-group>. (<year>2002</year>). <article-title>Identification of major outer surface proteins of <italic>Streptococcus agalactiae</italic></article-title>. <source>Infect. Immun.</source> <volume>70</volume>, <fpage>1254</fpage>&#x02013;<lpage>1259</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.70.3.1254-1259.2002</pub-id><pub-id pub-id-type="pmid">11854208</pub-id></citation>
</ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Janero</surname> <given-names>D. R.</given-names></name> <name><surname>Hreniuk</surname> <given-names>D.</given-names></name></person-group> (<year>1996</year>). <article-title>Suppression of TCA cycle activity in the cardiac muscle cell by hydroperoxide-induced oxidant stress</article-title>. <source>Am. J. Physiol.</source> <volume>270</volume>, <fpage>C1735</fpage>&#x02013;<lpage>C1742</lpage>. <pub-id pub-id-type="pmid">8764157</pub-id></citation>
</ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson-Henry</surname> <given-names>K. C.</given-names></name> <name><surname>Mitchell</surname> <given-names>D. J.</given-names></name> <name><surname>Avitzur</surname> <given-names>Y.</given-names></name> <name><surname>Galindo-Mata</surname> <given-names>E.</given-names></name> <name><surname>Jones</surname> <given-names>N. L.</given-names></name> <name><surname>Sherman</surname> <given-names>P. M.</given-names></name></person-group> (<year>2004</year>). <article-title>Probiotics reduce bacterial colonization and gastric inflammation in <italic>H</italic>. pylori-infected mice</article-title>. <source>Dig. Dis. Sci.</source> <volume>49</volume>, <fpage>1095</fpage>&#x02013;<lpage>1102</lpage>. <pub-id pub-id-type="doi">10.1023/B:DDAS.0000037794.02040.c2</pub-id><pub-id pub-id-type="pmid">15387328</pub-id></citation>
</ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karlenius</surname> <given-names>T. C.</given-names></name> <name><surname>Tonissen</surname> <given-names>K. F.</given-names></name></person-group> (<year>2010</year>). <article-title>Thioredoxin and cancer: a role for thioredoxin in all states of tumor oxygenation</article-title>. <source>Cancers (Basel)</source> <volume>2</volume>, <fpage>209</fpage>&#x02013;<lpage>232</lpage>. <pub-id pub-id-type="doi">10.3390/cancers2020209</pub-id><pub-id pub-id-type="pmid">24281068</pub-id></citation>
</ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khosravi</surname> <given-names>Y.</given-names></name> <name><surname>Dieye</surname> <given-names>Y.</given-names></name> <name><surname>Loke</surname> <given-names>M. F.</given-names></name> <name><surname>Goh</surname> <given-names>K. L.</given-names></name> <name><surname>Vadivelu</surname> <given-names>J.</given-names></name></person-group> (<year>2014b</year>). <article-title><italic>Streptococcus mitis</italic> induces conversion of <italic>Helicobacter pylori</italic> to coccoid cells during co-culture <italic>in vitro</italic></article-title>. <source>PLoS ONE</source> <volume>11</volume>:<fpage>e112214</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0112214</pub-id><pub-id pub-id-type="pmid">25386948</pub-id></citation>
</ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khosravi</surname> <given-names>Y.</given-names></name> <name><surname>Dieye</surname> <given-names>Y.</given-names></name> <name><surname>Poh</surname> <given-names>B. H.</given-names></name> <name><surname>Ng</surname> <given-names>C. G.</given-names></name> <name><surname>Loke</surname> <given-names>M. F.</given-names></name> <name><surname>Goh</surname> <given-names>K. L.</given-names></name> <etal/></person-group>. (<year>2014a</year>). <article-title>Culturable bacterial microbiota of the stomach of <italic>Helicobacter pylori</italic> positive and negative gastric disease patients</article-title>. <source>ScientificWorldJournal</source> <volume>2014</volume>:<fpage>610421</fpage>. <pub-id pub-id-type="doi">10.1155/2014/610421</pub-id><pub-id pub-id-type="pmid">25105162</pub-id></citation>
</ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>H. J.</given-names></name> <name><surname>Chae</surname> <given-names>H. Z.</given-names></name> <name><surname>Kim</surname> <given-names>Y. J.</given-names></name> <name><surname>Kim</surname> <given-names>Y. H.</given-names></name> <name><surname>Hwangs</surname> <given-names>T. S.</given-names></name> <name><surname>Park</surname> <given-names>E. M.</given-names></name> <etal/></person-group>. (<year>2003</year>). <article-title>Preferential elevation of Prx, I., and Trx expression in lung cancer cells following hypoxia and in human lung cancer tissues</article-title>. <source>Cell. Biol. Toxicol.</source> <volume>19</volume>, <fpage>285</fpage>&#x02013;<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1023/B:CBTO.0000004952.07979.3d</pub-id><pub-id pub-id-type="pmid">14703116</pub-id></citation>
</ref>
<ref id="B21">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kusters</surname> <given-names>J. G.</given-names></name> <name><surname>van Vliet</surname> <given-names>A. H. M.</given-names></name> <name><surname>Kuipers</surname> <given-names>E. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Pathogenesis of <italic>Helicobacter pylori</italic> infection</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>19</volume>, <fpage>449</fpage>&#x02013;<lpage>490</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00054-05</pub-id><pub-id pub-id-type="pmid">25167940</pub-id></citation>
</ref>
<ref id="B22">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>N.</given-names></name> <name><surname>Han</surname> <given-names>L.</given-names></name> <name><surname>Chen</surname> <given-names>J.</given-names></name> <name><surname>Lin</surname> <given-names>X.</given-names></name> <name><surname>Chen</surname> <given-names>H.</given-names></name> <name><surname>She</surname> <given-names>F.</given-names></name></person-group> (<year>2013</year>). <article-title>Proliferative and apoptotic effects of gastric epithelial cells induced by coccoid <italic>Helicobacter pylori</italic></article-title>. <source>J. Basic Microbiol.</source> <volume>53</volume>, <fpage>147</fpage>&#x02013;<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1002/jobm.201100370</pub-id><pub-id pub-id-type="pmid">22581720</pub-id></citation>
</ref>
<ref id="B23">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Loke</surname> <given-names>M. F.</given-names></name> <name><surname>Ng</surname> <given-names>C. G.</given-names></name> <name><surname>Vilashni</surname> <given-names>Y.</given-names></name> <name><surname>Lim</surname> <given-names>J.</given-names></name> <name><surname>Ho</surname> <given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title>Understanding the dimorphic lifestyles of human gastric pathogen <italic>Helicobacter pylori</italic> using the SWATH-based proteomics approach</article-title>. <source>Sci. Rep.</source> <volume>6</volume>:<fpage>26784</fpage>. <pub-id pub-id-type="doi">10.1038/srep26784</pub-id><pub-id pub-id-type="pmid">27222005</pub-id></citation>
</ref>
<ref id="B24">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname> <given-names>B. J.</given-names></name> <name><surname>Warren</surname> <given-names>J. R.</given-names></name></person-group> (<year>1984</year>). <article-title>Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration</article-title>. <source>Lancet</source> <volume>1</volume>, <fpage>1311</fpage>&#x02013;<lpage>1315</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(84)91816-6</pub-id><pub-id pub-id-type="pmid">6145023</pub-id></citation>
</ref>
<ref id="B25">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Obiageli</surname> <given-names>E. R.</given-names></name> <name><surname>Ivan</surname> <given-names>E. C.</given-names></name></person-group> (<year>2016</year>). <article-title>Prevalence of <italic>Helicobacter pylori</italic> and its associated peptic ulcer infection among adult residents of Aba, Southeastern Nigeria</article-title>. <source>Int. J. Curr. Microbiol. App. Sci.</source> <volume>5</volume>, <fpage>16</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.20546/ijcmas.2016.506.002</pub-id></citation>
</ref>
<ref id="B26">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raffel</surname> <given-names>J.</given-names></name> <name><surname>Bhattacharyya</surname> <given-names>A. K.</given-names></name> <name><surname>Gallegos</surname> <given-names>A.</given-names></name> <name><surname>Cui</surname> <given-names>H.</given-names></name> <name><surname>Einspahr</surname> <given-names>J. G.</given-names></name> <name><surname>Alberts</surname> <given-names>D. S.</given-names></name> <etal/></person-group>. (<year>2003</year>). <article-title>Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival</article-title>. <source>J. Lab. Clin. Med.</source> <volume>142</volume>, <fpage>46</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-2143(03)00068-4</pub-id><pub-id pub-id-type="pmid">12878985</pub-id></citation>
</ref>
<ref id="B27">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rolfe</surname> <given-names>R. D.</given-names></name> <name><surname>Hentges</surname> <given-names>G. J.</given-names></name> <name><surname>Barrett</surname> <given-names>J. T.</given-names></name> <name><surname>Campbell</surname> <given-names>B. J.</given-names></name></person-group> (<year>1997</year>). <article-title>Oxygen tolerance of human intestinal anaerobes</article-title>. <source>Am. J. Clin. Nutr.</source> <volume>30</volume>, <fpage>1762</fpage>&#x02013;<lpage>1769</lpage>. <pub-id pub-id-type="pmid">920635</pub-id></citation>
</ref>
<ref id="B28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname> <given-names>K. A.</given-names></name> <name><surname>Daly</surname> <given-names>P.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name> <name><surname>Hooton</surname> <given-names>C.</given-names></name> <name><surname>O&#x00027;Toole</surname> <given-names>P. W.</given-names></name></person-group> (<year>2008</year>). <article-title>Strain-specific inhibition of <italic>Helicobacter pylori</italic> by <italic>Lactobacillus salivarius</italic> and other lactobacilli</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>61</volume>, <fpage>831</fpage>&#x02013;<lpage>834</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkn040</pub-id><pub-id pub-id-type="pmid">18263567</pub-id></citation>
</ref>
<ref id="B29">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scharf</surname> <given-names>C.</given-names></name> <name><surname>Riethdorf</surname> <given-names>S.</given-names></name> <name><surname>Ernst</surname> <given-names>H.</given-names></name> <name><surname>Engelmann</surname> <given-names>S.</given-names></name> <name><surname>Volker</surname> <given-names>U.</given-names></name> <name><surname>Hecker</surname> <given-names>M.</given-names></name></person-group> (<year>1998</year>). <article-title>Thioredoxin is an essential protein induced by multiple stresses in <italic>Bacillus subtilis</italic></article-title>. <source>J. Bacteriol.</source> <volume>180</volume>, <fpage>1869</fpage>&#x02013;<lpage>1877</lpage>. <pub-id pub-id-type="pmid">9537387</pub-id></citation>
</ref>
<ref id="B30">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Solnick</surname> <given-names>J. V.</given-names></name> <name><surname>Chang</surname> <given-names>K.</given-names></name> <name><surname>Canfield</surname> <given-names>D. R.</given-names></name> <name><surname>Parsonnet</surname> <given-names>J.</given-names></name></person-group> (<year>2003</year>). <article-title>Natural acquisition of <italic>Helicobacter pylori</italic> infection in newborn rhesus macaques</article-title>. <source>J. Clin. Microbiol.</source> <volume>41</volume>, <fpage>5511</fpage>&#x02013;<lpage>5517</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.41.12.5511-5516.2003</pub-id><pub-id pub-id-type="pmid">14662932</pub-id></citation>
</ref>
<ref id="B31">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tally</surname> <given-names>F. P.</given-names></name> <name><surname>Stewart</surname> <given-names>P. R.</given-names></name> <name><surname>Sutter</surname> <given-names>V. L.</given-names></name> <name><surname>Rosenblatt</surname> <given-names>J. E.</given-names></name></person-group> (<year>1975</year>). <article-title>Oxygen tolerance of fresh clinical anaerobic bacteria</article-title>. <source>J. Clin. Microbiol.</source> <volume>1</volume>, <fpage>161</fpage>&#x02013;<lpage>165</lpage>. <pub-id pub-id-type="pmid">1176601</pub-id></citation>
</ref>
<ref id="B32">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trachootham</surname> <given-names>D.</given-names></name> <name><surname>Lu</surname> <given-names>W.</given-names></name> <name><surname>Ogasawara</surname> <given-names>M. A.</given-names></name> <name><surname>Nilsa</surname> <given-names>R. D.</given-names></name> <name><surname>Huang</surname> <given-names>P.</given-names></name></person-group> (<year>2008</year>). <article-title>Redox regulation of cell survival</article-title>. <source>Antioxid. Redox Signal.</source> <volume>10</volume>, <fpage>1343</fpage>&#x02013;<lpage>1374</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2007.1957</pub-id><pub-id pub-id-type="pmid">18522489</pub-id></citation>
</ref>
<ref id="B33">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uziel</surname> <given-names>O.</given-names></name> <name><surname>Borovok</surname> <given-names>I.</given-names></name> <name><surname>Schreiber</surname> <given-names>R.</given-names></name> <name><surname>Cohen</surname> <given-names>G.</given-names></name> <name><surname>Aharonowitz</surname> <given-names>Y.</given-names></name></person-group> (<year>2004</year>). <article-title>Transcriptional regulation of the <italic>Staphylococcus aureus</italic> thioredoxin and thioredoxin reductase genes in response to oxygen and disulfide stress</article-title>. <source>J. Bacteriol.</source> <volume>186</volume>, <fpage>326</fpage>&#x02013;<lpage>334</lpage>. <pub-id pub-id-type="doi">10.1128/JB.186.2.326-334.2004</pub-id><pub-id pub-id-type="pmid">14702300</pub-id></citation>
</ref>
<ref id="B34">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilkins</surname> <given-names>J. C.</given-names></name> <name><surname>Beighton</surname> <given-names>D.</given-names></name> <name><surname>Homer</surname> <given-names>K. A.</given-names></name></person-group> (<year>2003</year>). <article-title>Effect of acidic pH on expression of surface-associated proteins of <italic>Streptococcus oralis</italic></article-title>. <source>Appl. Environ. Microbiol.</source> <volume>69</volume>, <fpage>5290</fpage>&#x02013;<lpage>5296</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.69.9.5290-5296.2003</pub-id><pub-id pub-id-type="pmid">12957916</pub-id></citation>
</ref>
<ref id="B35">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname> <given-names>A.</given-names></name> <name><surname>Tani</surname> <given-names>K.</given-names></name></person-group> (<year>1983</year>). <article-title>Phosphoglycerate kinase abnormalities: functional, structural and genomic aspects</article-title>. <source>Biomed. Biochim. Acta</source> <volume>42</volume>, <fpage>S263</fpage>&#x02013;<lpage>S267</lpage>. <pub-id pub-id-type="pmid">6689547</pub-id></citation>
</ref>
</ref-list>
</back>
</article>